Scientech Research LLC raised its holdings in shares of Entegris, Inc. (NASDAQ:ENTG - Free Report) by 440.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,305 shares of the semiconductor company's stock after acquiring an additional 12,472 shares during the quarter. Entegris makes up 0.4% of Scientech Research LLC's investment portfolio, making the stock its 26th largest position. Scientech Research LLC's holdings in Entegris were worth $1,516,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. Siemens Fonds Invest GmbH purchased a new stake in Entegris during the 4th quarter worth about $3,351,000. Sora Investors LLC acquired a new position in shares of Entegris in the fourth quarter valued at approximately $7,076,000. Polar Asset Management Partners Inc. boosted its position in Entegris by 192.0% during the fourth quarter. Polar Asset Management Partners Inc. now owns 153,900 shares of the semiconductor company's stock worth $15,245,000 after acquiring an additional 101,200 shares during the last quarter. ProShare Advisors LLC grew its stake in Entegris by 1.5% in the 4th quarter. ProShare Advisors LLC now owns 22,318 shares of the semiconductor company's stock worth $2,211,000 after acquiring an additional 324 shares during the period. Finally, Quantinno Capital Management LP lifted its stake in shares of Entegris by 11.6% during the 4th quarter. Quantinno Capital Management LP now owns 34,797 shares of the semiconductor company's stock worth $3,447,000 after purchasing an additional 3,607 shares during the period.
Entegris Stock Performance
Entegris stock traded up $1.12 on Thursday, reaching $73.55. 1,032,025 shares of the stock were exchanged, compared to its average volume of 2,488,500. The stock has a market cap of $11.14 billion, a PE ratio of 37.99, a PEG ratio of 1.50 and a beta of 1.33. The company has a current ratio of 3.08, a quick ratio of 1.86 and a debt-to-equity ratio of 1.08. Entegris, Inc. has a twelve month low of $60.75 and a twelve month high of $147.57. The firm has a fifty day moving average price of $79.90 and a two-hundred day moving average price of $95.15.
Entegris (NASDAQ:ENTG - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The semiconductor company reported $0.67 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.02). Entegris had a return on equity of 12.83% and a net margin of 9.03%. The business had revenue of $773.20 million during the quarter, compared to the consensus estimate of $790.75 million. During the same quarter in the previous year, the firm posted $0.68 earnings per share. The company's revenue for the quarter was up .3% on a year-over-year basis. Sell-side analysts anticipate that Entegris, Inc. will post 3.51 EPS for the current year.
Entegris Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 21st. Stockholders of record on Wednesday, April 30th were given a dividend of $0.10 per share. The ex-dividend date was Wednesday, April 30th. This represents a $0.40 annualized dividend and a dividend yield of 0.54%. Entegris's dividend payout ratio (DPR) is currently 19.61%.
Insider Activity
In other Entegris news, SVP Olivier Blachier sold 984 shares of the company's stock in a transaction on Friday, February 21st. The shares were sold at an average price of $108.00, for a total transaction of $106,272.00. Following the completion of the sale, the senior vice president now owns 10,903 shares in the company, valued at approximately $1,177,524. The trade was a 8.28% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.67% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. UBS Group cut their price objective on shares of Entegris from $90.00 to $85.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Wall Street Zen cut Entegris from a "hold" rating to a "sell" rating in a report on Saturday, April 19th. Needham & Company LLC reiterated a "buy" rating and issued a $100.00 price target on shares of Entegris in a research note on Tuesday. KeyCorp decreased their price target on Entegris from $130.00 to $117.00 and set an "overweight" rating for the company in a research note on Thursday, May 8th. Finally, Citigroup cut their target price on Entegris from $125.00 to $102.00 and set a "buy" rating on the stock in a research note on Thursday, May 8th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $113.00.
Get Our Latest Report on Entegris
Entegris Company Profile
(
Free Report)
Entegris, Inc develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions in North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. It operates in three segments: Materials Solutions (MS); Microcontamination Control (MC); and Advanced Materials Handling (AMH).
Featured Articles

Before you consider Entegris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Entegris wasn't on the list.
While Entegris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.